Mayka Sanchez: Updates from EFAPH 2026 Meeting
Mayka Sanchez, Associate Professor and Senior Group Leader at International University of Catalonia, shared a post on LinkedIn:
“Great to be in Dublin for the annual meeting of European Federation of Associations of Patients with Haemochromatosis (EFAPH), bringing together patient representatives, clinicians, and researchers committed to improving care for people living with haemochromatosis.
The meeting included an excellent Clinical Expert Session featuring a keynote presentation by Domenico Girelli, alongside an update on the CSL Ferroclear haemochromatosis clinical trial project and its potential implications for future treatment options.
A valuable opportunity to exchange knowledge, strengthen collaborations, and discuss the future of haemochromatosis research and patient care.”

Stay updated with Hemostasis Today.
-
Nov 15, 2026, 16:29Jean-Jacques Kiladjian: 20 Years of Interferon-Alpha Research in Myeloproliferative Neoplasms
-
Nov 15, 2026, 16:21Sukanto Paul: Why Platelet Transfusion Is Generally Avoided in TTP
-
Nov 15, 2026, 16:14Ahmad G. Alzahrani: Major Bleeding and Anticoagulant Reversal
-
Nov 15, 2026, 16:05Sabine Eichinger: Is Recurrence Risk After Provoked VTE Really Low?
-
Nov 15, 2026, 15:53Nicolas Schommer: The Seed and Soil Hypothesis of NET-Mediated Inflammation
-
Nov 15, 2026, 15:36Giovanni Merlino: Targeting LDL-C to Prevent Recurrent Stroke
-
Nov 15, 2026, 15:33Riitta Lassila: From Helsinki to ISTH 2027 Advancing Thrombosis Research
-
Nov 15, 2026, 15:30Andreas Calatzis: Can Protein C and Plasma Overcome Fibrinolysis Resistance in Sepsis?
-
Nov 15, 2026, 15:25Hussnain Javaid: Thalassaemia 2026 New Therapies Transforming UK Practice